Talphera (TLPH) Return on Invested Capital (2016 - 2023)
Talphera's (TLPH) quarterly Return on Invested Capital came in at 0.04% in Q4 2023, down 3.0% year-on-year from 0.04% in Q4 2022, and down 119.92% quarter-over-quarter from 0.02% in Q3 2023.
Talphera (TLPH) Return on Invested Capital (2016 - 2023) Analysis & Trends
Talphera's Return on Invested Capital history runs 8 years deep, the most recent figure standing at 0.04% for Q4 2023.
- On a quarterly basis, Return on Invested Capital fell 3.0% year-over-year to 0.04% in Q4 2023; TTM through Dec 2023 was 0.04%, a 3.0% decrease from a year earlier, with the FY2022 full-year figure at 0.03%, changed 0.0% from the prior year.
- Return on Invested Capital declined to 0.04% in Q4 2023 per TLPH's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.01% in Q4 2021 and bottomed at 0.04% in Q4 2023.
- The 5-year median for Return on Invested Capital is 0.01% (2020), against an average of 0.02%.
- Across the five-year window, Return on Invested Capital climbed 2 bps in 2020 and decreased 3 bps in 2023, its largest moves.
- Year by year, Return on Invested Capital stood at 0.03% in 2019, then surged by 54 bps to 0.01% in 2020, then jumped by 39 bps to 0.01% in 2021, then decreased by 2 bps to 0.01% in 2022, then plunged by 414 bps to 0.04% in 2023.
- Per Business Quant, the three latest TLPH Return on Invested Capital figures stand at 0.04% (Q4 2023), 0.02% (Q3 2023), and 0.01% (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.02% |
| Jun 30, 2020 | -0.03% |
| Dec 31, 2019 | -0.03% |
| Sep 30, 2019 | -0.02% |
| Jun 30, 2019 | -0.01% |
| Dec 31, 2018 | -0.02% |
| Sep 30, 2018 | -0.02% |
| Jun 30, 2018 | -0.02% |
| Dec 31, 2017 | -0.02% |
| Sep 30, 2017 | -0.01% |